ArticleHealth economics review2020

The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany.

C M Dintsios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.